Insulin autoimmune syndrome (Hirata disease): Epidemiology in Asia, including Japan

Diabetology International

Volumn 1, Issue 1, 2010, Pages 21-25

  Uchigata, Yasuko ^a   Hirata, Yukimasa ^a   Iwamoto, Yasuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Alpha lipoic acid; HLA; Hypoglycemia; Insulin autoimmune syndrome; Methimazole

Indexed keywords

CARBIMAZOLE; DEATH RECEPTOR 4; GLUTATHIONE; INSULIN; THIAMAZOLE; THIOCTIC ACID; THIOL GROUP; TIOPRONIN;

AUTOIMMUNE DISEASE; CATARACT; CHEYLETIELLOSIS; CHRONIC HEPATITIS; CLINICAL FEATURE; DERMATITIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG EXPOSURE; DRUG WITHDRAWAL; GRAVES DISEASE; HIRATA DISEASE; HUMAN; HYPOGLYCEMIA; INSULIN AUTOIMMUNE SYNDROME; JAPAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; URTICARIA;

EID: 84861660625     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-010-0001-z     Document Type: Review

References (25)

1. Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case of spontaneous hypoglycemia. J Jpn Diabetes Soc. 1970; 13: 312-20.
2. Uchigata Y, Eguchi Y, Takayama-Hasumi S, et al. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract. 1994; 22: 89-94.
3. Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in incidence of insulin autoimmune syndrome (IAS, Hirata's Disease) with respect to the evolution of HLA-DR4. Hum Genet. 2000; 61: 154-7.
4. Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine. 2009; 88: 141-53.
5. Uchigata Y, Omori Y. Clinical characteristics of 212 patients with insulin autoimmune syndrome (Hirata Disease) (in Japanese). Hormone Pract. 1994; 42(Suppl): 229-32.
6. Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet. 1983; ii: 1037-1038.
7. Uchigata Y, Kuwata S, Tsushima T, et al. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab. 1993; 77: 249-54.
8. Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009; 83: e19-20.
9. Wasada T, Eguchi Y, Takayama S, Hirata Y, Ishii S. Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Diabetes Care. 1989; 12: 147-50.
10. Murakami M, Mizuida M, Kashima K, Kojima A, Tomioka SI, Kohama T, Araki O, Ogiwara T, Mizuma H, Mori M. Identification of monoclonal insulin autoantibodies in insulin autoimmune syndrome associated with HLA-DRB1*0404. Hormone Res. 2000; 54: 49-52.
11. Miyake T, Tsujimura F, Ito Y. A case of monoclonal insulin autoimmune syndrome with a suspected 20-year history: effect of one-year administration of prednisolone on insulin autoantibodies. J Jpn Diab Soc. 2009; 52: 45-9.
12. Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata's disease) and monoclonal insulin autoimmune syndrome. Diabetes. 1995; 44: 1227-32.
13. Masjhur JS. Insulin autoimmune syndrome (Hirata's Disease): severe hypoglycemic episodes in Graves's hyperthyroidism patient treated with methimazole. Acta Media Indonesiana. 2005; 37: 214-6.
14. Uchigata Y, Omori Y, Nieda M, et al. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet. 1992; 340: 1467.
15. Ito Y, Nieda M, Uchigata Y, et al. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol. 1993; 15: 5770-6.
16. Miyamura N, Murata Y, Takeda K, Ichihara T, Matsumura H, Tokunaga K, Matsumoto M, Sakakida M, Araki E. A case of insulin autoimmune syndrome with HLADRB1*0404: impact on the hypothesis for the molecular pathogenesis involving DRB1 molecules. Diabet Med. 2006; 23: 103-6.
17. Kishikawa H, Okada Y, Hirose A, Kawahara T, Misawa H, Tanikawa T, Kanda K, Morita E, Tanaka Y. A case of insulin autoimmune syndrome whom the development of IAS was probably induced by Loxoprofen sodium. J Jpn Diab Soc. 2004; 47: 851-4.
18. Benson EB, Ho P, Wang C, et al. Insulin autoimmunity as a cause of hypoglycemia. Arch Intern Med. 1984; 144: 2351-4.
19. Cho BY, Lee HK, Koh CS, et al. Spontaneous hypoglycemia and insulin autoantibodies in patients with Graves' disease. Diabetes Res Clin Pract. 1987; 3: 119-24.
20. Lee Y-J, Shin S-J, Torng J-K, et al. Insulin autoimmune syndrome in a methimazole-treated Graves' disease with polyclonal anti-insulin autoantibodies. J Formosa Med Assoc. 1987; 867: 164-70.
21. Lin H-D, Chen H-D, Chang R-Y, Lin C-Y, Ching K-N. Insulin autoimmune syndrome in methimazole or carbimazole treated Chinese patients of Graves' disease. Chin Med J. 1988; 42: 163-8.
22. Wong ST, Ng WY, Thai AC. Case report: autoimmune insulin syndrome in a Chinese female with Graves' disease. Ann Acad Med Singap. 1996; 25: 882-5.
23. Chen C-H, Huang M-J, Huang B-Y, et al. Insulin autoimmune syndrome as a cause of hypoglycemia--report of four cases. Changgeng Yi Xue Za Zhi. 1990; 13: 134-42.
24. Lu CC, Lee JK, Yang CY, Han TM. Insulin autoimmune syndrome in a patient with methimazole and carbimazole-treated Graves' disease: a case report. Chin Med J. 1994; 54(5): 353-8.
25. Ma WY, Won JG, Tang KT, Lin HD. Severe hypoglycemic coma due to insulin autoimmune syndrome. J Chin Med Assoc. 2005; 68: 82-6.